Participating Faculty for Moderate to Severe Psoriasis: Considerations for Patient Management Amid a Changing Treatment Spectrum

Supplements and Featured Publications, Moderate to Severe Psoriasis: Considerations for Patient Management Amid a Changing Treatment Spectrum, Volume 27, Issue 10

FACULTY

Jerry Bagel, MD, MS

Director

Psoriasis Treatment Center of New Jersey

East Windsor, New Jersey

Clinical Professor

Icahn School of Medicine at Mount Sinai

New York, New York

FACULTY DISCLOSURES

Jerry Bagel, MD, MS, has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:

BOARD MEMBERSHIP

The National Psoriasis Foundation, Board of Directors

CONSULTANCIES OR PAID ADVISORY BOARDS

AbbVie, Janssen Pharmaceuticals, Arcutis Biotherapeutics

GRANTS RECEIVED

AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Novartis,
Sun Pharma, UCB

LECTURE FEES FOR SPEAKING AT THE INVITATION OF A COMMERCIAL SPONSOR

AbbVie, Eli Lilly and Company, Janssen Pharmaceuticals